참고문헌
- 우리나라 신대체 요법의 현황-대한신장학회 말기 신부전 환자 등록사업 2008, 대한 신장학회지 28:S493-510, 2009
- Excerpts From the United States Renal Data System-2009 Annual Data Report: Atlas of Chronic Kidney Disease & End-Stage Renal Disease in the United States. Am J Kidney Dis 55(1), Suppl 1:S269-280, 2009
- 서혜진, 현승혜, 김건현, 전주현, 최지영, 조지형, 김찬덕, 박선희, 김용림. 대한내과학회지 79:258-262, 2010
- Ersoy FF. Improving Technique Survival in Peritoneal Dialysis: What is Modifiable? Perit Dial Int 29, Suppl 2:S74-S77, 2009
- Piraino B, Bailie GR, Bernardini J, Boeschoten E, Gupta A, Holmes C, Kuijper EJ, Li PK, Lye WC, Mujais S, Paterson DL, Fontan MP, Ramos A, Schaefer F, Uttley L; ISPD Ad Hoc Advisory Committee. Peritoneal Dialysis-Related Infections Recommendation: 2005 update Perit Dial Int 25:107-131, 2005
- Williams JD, Craig KJ, von Ruhland C, Topley N, Williams GT. Biopsy Registry Study Group. The natural course of peritoneal membrane biology during peritoneal dialysis. Kidney Int 64,Suppl 88:S43-S49, 2003
- Li PK, Chow KM, Wong TY, Leung CB, Szeto CC. Effects of angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. A randomized, controlled study. Ann Intern Med 139:105-112, 2003
- Mortier S, Faict D, Schalkwijk CG, Lameire NH, De Vriese AS. Long-term exposure to new peritoneal dialysis solutions: Effects on the peritoneal membrane. Kidney Int 66:408-418, 2004 https://doi.org/10.1111/j.1523-1755.2004.00747.x